12 Jun 2013, BioSpectrum Bureau , BioSpectrum
Singapore: A delegation of Trade and Economic Ministers from the Association of Southeast Asian Nations (ASEAN) region visited Covidien's manufacturing and R&D facility in Irvine, California, US. Covidien is a global provider of healthcare products, manufactures neurovascular devices at the facility, which are used around the world as part of minimally-invasive surgical procedures to treat and save the lives of stroke victims.
Following the tour at the facility, Mr Lim Hong Hin, deputy secretary general of ASEAN for ASEAN Economic Community, said, "It was important to visit this facility in order to learn about some of the most advanced technologies in the medical device industry, and how these can contribute to bettering the health and lives of many people in our region."
Organized by the US-ASEAN Business Council of Washington DC the group is visiting several enterprises in the US. The visit will conclude on June 13 in Washington DC, US.
Mr Harry de Wit, president, Asia, Covidien, said, "We are honored that this delegation of senior Ministers from 10 markets in Asia chose to visit our facility to see first-hand the innovation and skill that goes into the production of these intricate medical devices. As part of the visit, we briefed the Ministers on some of our groundbreaking products, such as a device used to treat patients with complex brain aneurysms."
He added, "Several of the products manufactured at our facility are already used by neurointerventionalists in some markets in ASEAN. These products have the potential to limit or prevent the damage a stroke can have on the brain. Access to these products is a major shift in neurosurgery. It moves us from open surgery to minimally invasive techniques. I hope this visit will further open the door for these life-saving technologies in the Asian markets."